Karyopharm to Participate at Upcoming Investor Conferences

On September 7, 2022 Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, reported that the Company’s senior management team will participate in the following investor conferences in September (Press release, Karyopharm, SEP 7, 2022, View Source [SID1234619162]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 20th Annual Global Healthcare Conference
Format: Fireside chat
Date: Monday, September 12, 2022
Time: 12:30 p.m. ET

Baird 2022 Global Healthcare Conference
Format: Fireside chat
Date: Tuesday, September 13, 2022
Time: 12:50 p.m. ET

A live webcast of the fireside chats, along with accompanying slides, can be accessed under "Events & Presentations" in the Investor section of the Company’s website, View Source, and will be available for replay for 90 days following each fireside chat.